Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study. Source: International Congress 2019 – More and more COPD Year: 2019
Beta-blocker use is associated with lower mortality following myocardial infarction in patients with and without COPD. A Danish nationwide cohort study. Source: International Congress 2019 – More and more COPD Year: 2019
Exacerbation frequency and increased risk of myocardial infarction in COPD Source: Annual Congress 2008 - COPD and comorbidities Year: 2008
Myocardial infarction, heart failure and mortality in patients with COPD in primary care. Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Effect of severity of exacerbations of COPD and hospitalised pneumonia on risk of myocardial infarction Source: International Congress 2017 – COPD: risk factors and prognosis Year: 2017
Acute myocardial infarction is associated with increased number of bronchial macrophages in low risk patients Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011
COPD and acute myocardial infarction Source: Eur Respir Rev, 29 (156) 190139; 10.1183/16000617.0139-2019 Year: 2020
Mortality and acute exacerbation of COPD: a pilot study on the influence of myocardial injury Source: Eur Respir J, 49 (6) 1700096; 10.1183/13993003.00096-2017 Year: 2017
The prevalence of COPD in patients participated in rehabilitation program after myocardial infarction Source: Annual Congress 2013 –COPD mechanisms Year: 2013
Short-term risk of acute myocardial infarction among patients with community-acquired pneumonia Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010
Underlying ischaemic heart disease assessed by cardiac infarction injury score (CIIS) is under-recognised in our patients hospitalised for COPD exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Acute myocardial infarction in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Current trends in the course, treatment, and outcomes of ST-segment elevation myocardial infarction (STEMI) in patients with COPD. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020
Heart remodeling in patients after St-segment elevation myocardial infarction with and without concomitant COPD. Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020
Association between lung function and future risks of diabetes, asthma, myocardial infarction, hypertension and all-cause mortality Source: ERJ Open Res, 7 (3) 00178-2021; 10.1183/23120541.00178-2021 Year: 2021
Clinical features of hospital-aquired pneumonia in patients with myocardial infarction Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008
Determinants of 6-months mortality in elderly patients admitted for non-acidotic acute exacerbation of COPD (AECOPD) Source: Annual Congress 2007 - COPD and comorbidity Year: 2007
Comparative analysis of global longitudinal strain in patients with ST-segment elevation myocardial infarction (STEMI) with and without concomitant COPD. Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019
COPD in patients evaluated for stable myocardial ischemia – observational study Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018
Passive smoking and risk of fatal and non-fatal myocardial infarction in a cohort of Danish workers Source: Annual Congress 2008 - Environmental tobacco smoke and smoking ban Year: 2008